In comparison with normal cells, cancer cells exhibit an elevated level of DNA damage due to oncogene-induced replication stress (RS) leading to hyperproliferation as well as oncogenic mutations in crucial players of the DDR (e.g., ATM, ATR, BRCA1, BRCA2, and TP53). This evidence concerns the gene BRCA2 and cancer.